|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0003873,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0231448,
umls-concept:C0439064,
umls-concept:C0443252,
umls-concept:C0596545,
umls-concept:C0681906,
umls-concept:C0717758,
umls-concept:C2587213,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-3-15
|
|
pubmed:abstractText |
The impact of long-term therapy for rheumatoid arthritis (RA) in elderly (> or = 65 years of age) and younger (< 65 years of age) patients, especially on patient-reported outcomes, has not been well studied. We evaluated patient-reported outcomes in elderly patients treated with etanercept, in contrast to outcomes in younger patients, using data from multiple controlled and open-label extension studies of patients with early RA (ERA; < or = 3 years) and late RA (LRA; disease-modifying antirheumatic drug [DMARD]-refractory RA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1170-229X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
167-78
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16536638-Age Factors,
pubmed-meshheading:16536638-Aged,
pubmed-meshheading:16536638-Antirheumatic Agents,
pubmed-meshheading:16536638-Arthritis, Rheumatoid,
pubmed-meshheading:16536638-Drug Administration Schedule,
pubmed-meshheading:16536638-Health Status,
pubmed-meshheading:16536638-Humans,
pubmed-meshheading:16536638-Immunoglobulin G,
pubmed-meshheading:16536638-Methotrexate,
pubmed-meshheading:16536638-Middle Aged,
pubmed-meshheading:16536638-Quality of Life,
pubmed-meshheading:16536638-Questionnaires,
pubmed-meshheading:16536638-Randomized Controlled Trials as Topic,
pubmed-meshheading:16536638-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:16536638-Severity of Illness Index,
pubmed-meshheading:16536638-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
|
|
pubmed:affiliation |
Denver Arthritis Clinic, University of Colorado, Denver, Colorado 80230, USA. crendon@denverarthritisclinic.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
